Ramy Younes

Ramy Younes

Company: Boehringer Ingelheim

Job title: Hepatologist & Clinical Program Leader NASH/Metabolism


Drug Induced Liver Injury (DILI): Impacts on Liver Functionality & Influence on NASH Drug Development 4:30 pm

• Uncovering why DILI is a common liver issue in clinical trials • Revealing the reasons why NASH patients have different level of alteration of liver enzymes • Appreciating the fact that the assessment of DILI in NASH trials requires careful planning and evaluationRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.